Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia. | Clin Sci (Lond) | 2020 | 33201243 | PubTator, text mining | PubMed |
| Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome. | Front Oncol | 2020 | 33194691 | PubTator, text mining | PubMed |
| Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway. | Front Pharmacol | 2020 | 33192510 | PubTator, text mining | PubMed |
| Plasmacytoid Dendritic Cell Infiltration in Acute Myeloid Leukemia. | Cancer Manag Res | 2020 | 33192098 | PubTator, text mining | PubMed |
| 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts. | BMC Cancer | 2020 | 33176741 | PubTator, text mining | PubMed |
| Supramolecular Organization As a Factor of Ribonuclease Cytotoxicity. | Acta Naturae | 2020 | 33173594 | PubTator, text mining | PubMed |
| Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development. | Med Oncol | 2020 | 33170359 | PubTator, text mining | PubMed |
| Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis. | Epigenetics Chromatin | 2020 | 33168103 | PubTator, text mining | PubMed |
| Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study. | PLoS One | 2020 | 33166299 | PubTator, text mining | PubMed |
| The role of m6A modification in physiology and disease. | Cell Death Dis | 2020 | 33162550 | PubTator, text mining | PubMed |
| RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia. | Exp Hematol | 2020 | 33152396 | PubTator, text mining | PubMed |
| Acute Myeloid Sarcoma: An Unusual Cause of Diarrhea. | Cureus | 2020 | 33150100 | PubTator, text mining | PubMed |
| Analgesic medicines for adults with low back pain: protocol for a systematic review and network meta-analysis. | Syst Rev | 2020 | 33148322 | PubTator, text mining | PubMed |
| Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category. | Cancers (Basel) | 2020 | 33143086 | PubTator, text mining | PubMed |
| Mutations in normal tissues-some diagnostic and clinical implications. | BMC Med | 2020 | 33115454 | PubTator, text mining | PubMed |
| [Combination of interferon alpha-1b, interleukin-2 and thalidomide as maintenance therapy on acute myeloid leukemia patients with negative minimal residual disease]. | Zhonghua Xue Ye Xue Za Zhi | 2020 | 33113610 | PubTator, text mining | PubMed |
| Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma. | Cancers (Basel) | 2020 | 33105726 | PubTator, text mining | PubMed |
| Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS). | Case Rep Hematol | 2020 | 33101740 | PubTator, text mining | PubMed |
| DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML. | Cancers (Basel) | 2020 | 33080932 | PubTator, text mining | PubMed |
| Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? | Cells | 2020 | 33080779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=73